$66.20
À la fermeture: Nov 4 EDT
$66.94
0.741.12%
Pré-commercialisation: 4:07 AM EDT
Comments
Loading...
Orientation et prévision
Halozyme Therapeutics publie des prévisions sur le BPA et les revenus futurs, donnant aux investisseurs un aperçu du montant que la société s'attend à gagner au cours des prochaines périodes.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
11/03/2025 | HALO | Halozyme Therapeutics | FY | 2025 | $6.10 | $6.50 | $5.46 | $1.30B | $1.38B | $1.32B | |
10/01/2025 | HALO | Halozyme Therapeutics | FY | 2025 | $6.00 | $6.40 | $5.97 | $1.27B | $1.35B | $1.32B | |
08/05/2025 | HALO | Halozyme Therapeutics | FY | 2025 | $6.00 | $6.40 | $5.31 | $1.27B | $1.35B | $1.25B | |
05/06/2025 | HALO | Halozyme Therapeutics | FY | 2025 | $5.30 | $5.70 | $5.00 | $1.20B | $1.28B | $1.19B | |
02/18/2025 | HALO | Halozyme Therapeutics | FY | 2025 | $4.95 | $5.35 | $5.05 | $1.15B | $1.23B | $1.18B | |
01/08/2025 | HALO | Halozyme Therapeutics | FY | 2024 | $4.00 | $4.20 | $4.14 | $970.00M | $1.02B | $1.00B | |
01/08/2025 | HALO | Halozyme Therapeutics | FY | 2025 | $4.95 | $5.35 | $4.69 | $1.15B | $1.23B | $1.16B | |
10/31/2024 | HALO | Halozyme Therapeutics | FY | 2024 | $4.00 | $4.20 | $3.96 | $970.00M | $1.02B | $983.85M | |
08/06/2024 | HALO | Halozyme Therapeutics | FY | 2024 | $3.65 | $4.05 | $3.99 | $935.00M | $1.01B | $989.87M | |
06/06/2024 | HALO | Halozyme Therapeutics | FY | 2024 | $3.65 | $4.05 | $3.73 | $935.00M | $1.01B | $947.33M | |
05/07/2024 | HALO | Halozyme Therapeutics | FY | 2024 | $3.55 | $3.90 | $3.68 | $915.00M | $985.00M | $951.47M | |
02/20/2024 | HALO | Halozyme Therapeutics | FY | 2024 | $3.55 | $3.90 | $3.51 | $915.00M | $985.00M | $961.09M | |
01/17/2024 | HALO | Halozyme Therapeutics | FY | 2023 | $2.77 | $2.80 | $2.74 | $827.00M | $832.00M | $835.69M | |
11/06/2023 | HALO | Halozyme Therapeutics | FY | 2023 | $2.70 | $2.80 | $2.65 | $825.00M | $845.00M | $835.91M | |
08/08/2023 | HALO | Halozyme Therapeutics | FY | 2023 | $2.65 | $2.75 | $2.61 | $825.00M | $845.00M | $823.06M | |
05/09/2023 | HALO | Halozyme Therapeutics | FY | 2023 | $2.50 | $2.65 | $2.57 | $815.00M | $845.00M | $833.00M | |
03/15/2023 | HALO | Halozyme Therapeutics | FY | 2023 | — | — | — | $815.00M | $845.00M | $829.01M | |
02/21/2023 | HALO | Halozyme Therapeutics | FY | 2023 | $2.50 | $2.65 | $2.78 | $815.00M | $845.00M | $868.12M | |
01/10/2023 | HALO | Halozyme Therapeutics | FY | 2023 | $2.50 | $2.65 | $2.90 | $815.00M | $845.00M | $892.47M | |
11/08/2022 | HALO | Halozyme Therapeutics | FY | 2022 | $2.10 | $2.25 | $2.04 | $655.00M | $685.00M | $661.33M | |
08/09/2022 | HALO | Halozyme Therapeutics | FY | 2022 | $2.10 | $2.25 | $2.23 | $655.00M | $685.00M | $610.87M | |
05/10/2022 | HALO | Halozyme Therapeutics | FY | 2022 | $2.05 | $2.20 | $2.23 | $530.00M | $560.00M | $566.18M | |
04/13/2022 | HALO | Halozyme Therapeutics | FY | 2022 | $2.05 | $2.20 | $2.18 | $530.00M | $560.00M | $553.27M | |
02/22/2022 | HALO | Halozyme Therapeutics | FY | 2022 | $2.05 | $2.20 | $2.18 | $530.00M | $560.00M | $554.20M | |
01/10/2022 | HALO | Halozyme Therapeutics | FY | 2022 | $2.05 | $2.20 | $2.68 | $530.00M | $560.00M | $569.39M | |
11/02/2021 | HALO | Halozyme Therapeutics | FY | 2021 | $1.90 | $2.00 | — | $430.00M | $445.00M | — | |
08/09/2021 | HALO | Halozyme Therapeutics | FY | 2021 | $1.85 | $2.00 | $1.41 | $425.00M | $445.00M | $404.56M | |
05/10/2021 | HALO | Halozyme Therapeutics | FY | 2021 | $1.55 | $1.70 | $1.55 | $375.00M | $395.00M | $389.96M | |
02/23/2021 | HALO | Halozyme Therapeutics | FY | 2021 | $1.40 | $1.55 | $1.70 | $375.00M | $395.00M | $400.15M |
FAQ
Quelles sont les dernières directives pour Halozyme Therapeutics (HALO) ?
Les dernières prévisions pour Halozyme Therapeutics (HALO) ont été communiquées le novembre 3, 2025 pour l'année complète 2025. L'entreprise a fourni des prévisions de bénéfice par action dans une fourchette de $6.10 à $6.50, par rapport à un BPA estimé de $5.46. De plus, Halozyme Therapeutics a prévu un chiffre d'affaires entre $1.30B et $1.38B pour le trimestre.
Parcourir guidance et prévisions sur toutes les actions.